Global Ganja Report

Panama may be the next Latin American country to pass a medical marijuana law, with the nation's National Assembly now debating a measure. But, in sharp contrast to that in neighboring Colombia, the Panamanian program would fly pretty close to the ground. In a play to social conservatives, the law would only allow imports, and users would be limited to extracts rather than herbaceous cannabis. And even this may face a fight from opposition lawmakers.

A cannabis "shatter" production lab in England's North East, said to be the first of its kind in the post-industrial region, was busted Oct. 12 in a paramilitary-style raid by the Northumbria Police. Local media show a squad of cops in full body armor breaking down the door and smashing the windows of a local property with buzz-saws, battering rams and pick-axes. Two arrests were made in the raid on the Croft Estate housing project in the town of Gateshead, just across the River Tyne from the historic city of Newcastle-upon-Tyne. An unspecified number of plants as well as butane and other equipment were seized.

It has been a long, slow ride for patients hoping to get access to medical marijuana in the Lone Star state—and then just special strains of low-THC cannabis, and only for those suffering from "intractable epilepsy." Three dispensaries are hoping to get final approval from Texas authorities to start cultivating next month. Of course, it will be several more months before they can actually begin distributing—and then ambiguities in the law may mean further delays. Activists and lawmakers are pushing both to clear things up and expand the scope of the program.

Hemp Business Journal reports that products infused with CBD oil are leading growth in hermp-derived products sold in the United States generally, which in 2016 had a collective retail value of $688 million. This figure represents a five year 22% compound annual growth rate (CAGR). Joining more traditional products such as shelled seed, protein powder, soaps and lotions, are growing lines of medicinal preparations such as CBD edibles. Hemp-derived cannabidiol (CBD) accounted for $130 million in sales last year.

Following last-minute changes, the lower house of Florida's legislature on May 2 voted 105-9 to pass HB 1397, ostensibly following through on the voter mandate to establish a medical marijuana program in the Sunshine State. But those last-minute changes included both a limit on the number of license holders—and a ban on actually smoking herbaceous cannabis. House sponsor and Republican leader Ray Rodrigues blamed fears of interference from the Trump administration, telling the Tampa Bay Times: "We have to make it legal and available to Florida residents, but we have to do it in such a way that it complies to the guidance we’ve been given by the federal government."

Wisconsin became the latest state to pass a strictly limited semblance of a medical marijuana law on April 18 as the arch-conservative Gov. Scott Walker signed Senate Bill 10, allowing patients to receive cannabidiol (CBD) extract from a physician or pharmacy with a prescription. The law, already passed by both houses of the legislature, takes effect immediately. It passed the Senate with only one dissenting vote, pointing to widespread support for the measure in the Badger State.

Prime Minister Justin Trudeau introduced legislation to legalize the recreational use of cannabis in Canada April 13, following through on a campaign pledge and ending a long wait by advocates and entrepreneurs. The new law would allow adults 18 and over to possess or share up to 30 grams of dried herbaceous cannabis, and to purchase cannabis or cannabis oil from retailers, to be regulated at the provincial level. Canadians would also be allowed to grow up to four plants per residence for personal use, and to prepare legal cannabis products at home. Cannabis-infused edibles are to be available for sale after the regulatory framework is developed and brought into force.

The medical marjuana advocacy organization Mamá Cultiva, which has been campaigning on the issue across South America, is criticizing the new measure just passed by Argentina's Senate for failing to legalize personal cultivation. The Senate voted unanimously on March 29 to legalize cannabis oil and other derivatives for medical purposes. Talking Drugs blog reports that the bill is set to become law immediately upon receiving President Mauricio Macri's signature, as it was already passed by the lower-house Chamber of Deputies in November. Under the law, patients must register with a planned national program to be overseen by the Ministry of Health.